Taking Flight: Louisiana’s First Sickle Cell Gene Therapy Patient Heads Home

For 23-year-old Daniel Cressy, the sky has always been the limit—but a biological barrier kept him grounded. Daniel, a Metairie native and aspiring pilot, has lived his life with Sickle Cell Disease (SCD), a genetic blood disorder that causes red blood cells to become hard and crescent-shaped. These “sickle” cells clog blood flow, leading to excruciating pain crises and organ damage.

Because of his condition, Daniel couldn’t pass the FAA medical exam required to get his commercial pilot’s license. But this April, history was made in New Orleans. After a grueling six-week stay at Manning Family Children’s Hospital, Daniel became the first person in Louisiana to head home after receiving a revolutionary gene therapy treatment.

---

The Science of a Cure

This isn’t just a new medicine; it’s a “functional cure.” The process is a marvel of modern biotechnology:

1. Harvesting: Last year, doctors collected Daniel’s stem cells.
2. Editing: Those cells were sent to a lab where CRISPR-like technology edited his DNA to stop the production of “sickle” hemoglobin.
3. Infusion: After undergoing intensive chemotherapy to clear out his old bone marrow, Daniel’s newly edited cells were infused back into his body.

Now, his body is beginning to produce healthy, round red blood cells for the first time in his life. As he walked out of the hospital to a “second line” celebration from doctors and nurses, Daniel carried a flight simulator in his arms—a symbol of the career he can finally pursue.

---

Spreading Awareness: How You Can Help

Daniel’s journey is a beacon of hope for the 100,000 Americans living with SCD, but the road to widespread access is long. Here is how you can support the cause:

• Educate & Share: Sickle cell disproportionately affects the Black community (1 in 13 Black babies are born with the trait). Share Daniel’s story using hashtags like #SickleCellAwareness and #CureSCD to show that a cure is no longer science fiction.
• Support Blood Donations: Many SCD patients still rely on regular transfusions. Donating blood—especially if you are of diverse ancestry—provides a vital lifeline.
• Advocate for Access: These treatments are historic but expensive. Support organizations like the Sickle Cell Disease Association of America (SCDAA) that fight for policy changes and affordable access to gene therapy.

Daniel is currently writing a book titled Blessing in the Skies. His story reminds us that with scientific innovation and community support, we can finally ground this disease for good.